Ajinomoto Bio-Pharma Services

San Diego, CA · Osaka, JP
Find alternatives to Ajinomoto Bio-Pharma Services for Oligonucleotide →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
83.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (12) ○ EMA GMP ✓ MHRA GMP (1) ✓ HC GMP (12)

Quick Facts: Ajinomoto Bio-Pharma Services

Signal Score
83.5/100 (as of 2026-10-29)
Quality Compliance
100.0/100
Headquarters
San Diego, CA · Osaka, JP
Modalities
Oligonucleotide, Biologics, AAV
Active Programs
No ClinicalTrials.gov matches confirmed — 6 partnership signals in press (announcements, not verified)
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Ajinomoto Bio-Pharma Services

Acquired Forge Biologics. Expanding into CGT.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
FDA InspectionsNo US records on file
MHRA GMP Certificates1 on record
Most Recent HC OutcomeCompliant · 2023-09-12
HC Attribution12 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 6 partnership announcements found in press monitoring.
Programs — no verified data
Sponsors— no verified data
ModalitiesOligonucleotide, Biologics, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 75.0
Strong parent backing: Ajinomoto Co. (2802.T)
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Strong parent backing: Ajinomoto Co. (2802.T)
Capacity 63.0
2 manufacturing sites
Sites: San Diego, CA, Osaka, Japan
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
Press Signals12 articles (not scored)
2 manufacturing sites

Ajinomoto Bio-Pharma Services MHRA GMP Compliance 1 certificates

2014-06
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK GMP 33833 Insp GMP 33833/586518-0001[H] AJINOMOTO ALTHEA INCORPORATED 92121-1205 2014-06-19 COMPLIANT
Source: MHRA GMDP Database · Retrieved Nov 21, 2026

Japan-accredited overseas site (PMDA)

No current accreditation on PMDA's list.

Previously accredited (cancelled) · 1
  • San Diego, United States · Ajinomoto Althea, Inc. (2 sites) — sterile, biologics, packaging/storage only · cancelled Oct 6, 2025

No longer on PMDA's current list. Shown for history only; not used in search tags.

PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Nov 20, 2026

Company Signals 12 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-10-10
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand Identity - BioPharma APAC
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand Identity  BioPharma APAC
regulatory 2026-04-18
Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to support ADC development and manufacturing - BioSpectrum India
Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to support ADC development and manufacturing  BioSpectrum India
regulatory 2026-04-18
Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to support ADC development and manufacturing - BioSpectrum India
Piramal Pharma Solutions partners with Ajinomoto Bio-Pharma Services to support ADC development and manufacturing  BioSpectrum India
regulatory 2026-04-17
Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development - Indian Pharma Post
Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development  Indian Pharma Post
partnership 2026-04-16
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing - Yahoo Finance
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing  Yahoo Finance
partnership 2026-04-16
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing - PA Media
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing  PA Media
partnership 2026-04-16
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing - acrofan.com
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing  acrofan.com
partnership 2026-04-16
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing - digitalmore.co
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing  digitalmore.co
partnership 2026-04-16
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing - PR Newswire
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing  PR Newswire
partnership 2026-04-16
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and... - lokmattimes.com
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and...  lokmattimes.com
general 2026-04-16
Piramal Pharma Solutions und Ajinomoto Bio-Pharma Services arbeiten zusammen, um die Entwicklung und Herstellung von ADCs zu unterstützen - PR Newswire
Piramal Pharma Solutions und Ajinomoto Bio-Pharma Services arbeiten zusammen, um die Entwicklung und Herstellung von ADCs zu unterstützen  PR Newswire
regulatory 2026-04-16
Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development - Indian Pharma Post
Piramal Pharma, Ajinomoto Bio-Pharma collaborate to accelerate ADC development  Indian Pharma Post

Frequently Asked Questions About Ajinomoto Bio-Pharma Services

Does Ajinomoto Bio-Pharma Services hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 MHRA GMP certificate for Ajinomoto Bio-Pharma Services.
What is Ajinomoto Bio-Pharma Services's CDMO Signal Score?
Ajinomoto Bio-Pharma Services has a Signal Score of 84/100, based on quality, operations, financial stability, and capacity data.
Evaluating Ajinomoto Bio-Pharma Services for a manufacturing program?
Use the free AI matchmaker to compare Ajinomoto Bio-Pharma Services against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Oligonucleotide CDMOs → Biologics CDMOs → AAV CDMOs →

Similar CDMOs

FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
Lotte Biologics
Incheon, KR · Syracuse, NY
Signal Score: 81.6
Biologics, AAV
BioReliance (Merck)
Glasgow, UK · Rockville, MD
Signal Score: 80.3
AAV, Lentiviral, Biologics
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics

Compare Ajinomoto Bio-Pharma Services with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Ajinomoto Bio-Pharma Services
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.